Table 2.
Variables | Spearman’s correlation coefficient | P |
---|---|---|
Age (years) | −0.160 | 0.132 |
Height (cm) | −0.176 | 0.098 |
Body weight (kg) | −0.081 | 0.449 |
Waist circumference (cm) | 0.075 | 0.481 |
BMI (kg/m2) | 0.019 | 0.861 |
Systolic blood pressure (mmHg) | 0.124 | 0.243 |
Diastolic blood pressure (mmHg) | 0.007 | 0.950 |
Total cholesterol (mg/dL) | 0.111 | 0.296 |
Log-triglyceride (mg/dL) | 0.258 | 0.014* |
HDL-C (mg/dL) | −0.230 | 0.030* |
LDL-C (mg/dL) | 0.226 | 0.032* |
Log-glucose (mg/dL) | 0.088 | 0.412 |
Log-BUN (mg/dL) | 0.037 | 0.728 |
Log-creatinine (mg/dL) | 0.020 | 0.853 |
eGFR (mL/min) | −0.054 | 0.612 |
Log-CRP (mg/dL) | 0.082 | 0.442 |
Log-insulin (uIU/mL) | 0.049 | 0.649 |
Log-HOMA-IR | 0.078 | 0.465 |
Female, n (%) | 0.227 | 0.031* |
Hypertension, n (%) | 0.115 | 0.281 |
Diabetes, n (%) | 0.148 | 0.163 |
*P<0.05 was considered statistically significant (two-tailed). Data of triglyceride, glucose, blood urea nitrogen, creatinine, CRP, ANGPTL3, insulin, and HOMA-IR levels showed skewed distribution, and therefore were log-transformed before analysis. HDL-C: High density lipoprotein cholesterol, LDL-C: Low density lipoprotein cholesterol, BUN: Blood urea nitrogen, eGFR: Estimated glomerular filtration rate, CRP: C-reactive protein, HOMA-IR: Homeostasis model assessment of insulin resistance, ANGPTL3: Angiopoietin-like protein 3, ACE: Angiotensin-converting enzyme, ARB: Angiotensin-receptor blocker, CCB: Calcium-channel blocker, BMI: Body mass index